Loading Events

Mesoblast Key Opinion Leader Event Series for Investors & Analysts: Chronic Low Back Pain due to Degenerative Disc Disease

DATE: June 16, 2022

About The Event

The webinar will focus on the current treatment landscape and unmet medical need for patients with chronic low back pain (CLBP) due to degenerative disc disease, a condition associated with local inflammation in the disc. The webinar will feature presentations from Key Opinion Leaders (KOLs) Douglas P. Beall, MD, FIPP, FSIR, DAAPM (Clinical Radiology Oklahoma) and Hyun W. Bae, MD (Spine-Center at Cedars-Sinai Medical Center).
Mesoblast’s Chief Executive Silviu Itescu will provide an overview of the three-year outcomes from the completed 404 patient randomized controlled Phase 3 trial of rexlemestrocel-L in patients with CLBP due to degenerative disc disease and regulatory pathway to market.
A live question and answer session will follow.